Provider Perspectives on Use of Medical Marijuana in Children With Cancer
Prasanna Ananth(Yale University), Joanne Wolfe(Harvard University), Leah Kroon(Center for Cancer and Blood Disorders), Victoria Klein(Center for Cancer and Blood Disorders), Abby R. Rosenberg(Boston Children's Hospital), Elise Hallez(Lurie Children's Hospital), Ilana M. Braun(Harvard University), Clement Ma(University of Toronto), Kelly N. Michelson(Northwestern University), Wendy B. London(Dana-Farber Cancer Institute), Hasan Al‐Sayegh(Sultan Qaboos University), Claire Wharton(Center for Cancer and Blood Disorders)
Cited by 66
Related Papers
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci
|Nature Genetics|2015|426
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
|JAMA Neurology|2021|405
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|301